{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-23-001007","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.344115+00:00","generated_at":"2026-06-14T15:44:01.920216+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Anavex shareholders elect all six directors, ratify Grant Thornton LLP at 2023 annual meeting","bullets":["65% of outstanding shares (52.1M) represented at May 23, 2023 meeting.","All six director nominees elected, including CEO Christopher Missling (24.8M for, 1.9M withheld).","Ratification of Grant Thornton LLP as auditor passed with 51.1M for, 0.7M against, 0.3M abstain.","No broker non-votes on auditor ratification; all directors had ~25.3M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-23-001007","json":"https://secwatch.observer/filing/0001731122-23-001007.json","markdown":"https://secwatch.observer/filing/0001731122-23-001007.md","text":"https://secwatch.observer/filing/0001731122-23-001007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/0001731122-23-001007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/e4737_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T15:44:01.920216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11fd9728674131f97ad8c04913b0d1e96908fa3c","claim":"ANAVEX LIFE SCIENCES CORP. shareholders approved Election of six directors: Christopher Missling, PhD, Claus van der Velden, PhD, Athanasios Skarpelos, Jiong Ma, PhD, Steffen Thomas, PhD and Peter Donhauser, D.O. at the 2023-05-23 meeting.","evidence_excerpt":"The stockholders holding a majority of the Common Stock having voting power present in person or represented by proxy elected the six (6) directors by the following votes: Name For Withheld Broker Non-Votes Christopher Missling, PhD 24,844,203 1,895,064 25,349,339 Claus van der Velden, PhD 20,966,462 5,772,805 25,349,339 Athanasios Skarpelos 23,250,832 3,488,435 25,349,339 Jiong Ma, PhD 25,109,638 1,629,629 25,349,339 Steffen Thomas, PhD 25,236,805 1,502,462 25,349,339 Peter Donhauser, D.O. 25,186,408 1,552,859 25,349,339","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/0001731122-23-001007-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-23"}],"fact_type":"shareholder_vote"},{"claim_id":"a35460e68a51fd99ed05a614d2a3a73190513f56","claim":"ANAVEX LIFE SCIENCES CORP. shareholders approved Ratification of Grant Thornton LLP as the Company's independent registered accounting firm at the 2023-05-23 meeting.","evidence_excerpt":"The stockholders holding a majority of the Common Stock having voting power present in person or represented by proxy ratified Grant Thornton LLP as the Company’s independent registered accounting firm by the following votes: For Against Abstain Broker Non-Votes 51,086,713 709,931 291,962 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/0001731122-23-001007-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-23"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}